Patents for A61P 35 - Antineoplastic agents (221,099)
09/1997
09/18/1997CA2248076A1 Polymeric delivery of radionuclides and radiopharmaceuticals
09/18/1997CA2247888A1 Human bikunin
09/18/1997CA2225913A1 Persephin and related growth factors
09/17/1997EP0795556A1 4-Substituted pyrrolopyrimidine compounds as tyrosin kinase inhibitors
09/17/1997EP0795553A1 Production of isoflavone enriched fractions from soy protein extracts
09/17/1997EP0795334A2 Prodrugs for the treatment tumors and inflammatory diseases
09/17/1997EP0795328A1 Use of naphthalene derivatives in treating lung carcinoma
09/17/1997EP0795325A1 Plasmid entrapping multilamellar liposomes
09/17/1997EP0795015A1 Plasmids suitable for il-2 expression
09/17/1997EP0795006A1 HUMAN MutT2
09/17/1997EP0794966A1 Humanized antibodies to cd38
09/17/1997EP0794961A2 Lhrh antagonist peptides
09/17/1997EP0794955A1 Hindered n-oxide esters of rapamycin and their use as medicaments
09/17/1997EP0794954A1 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
09/17/1997EP0794953A1 Quinazoline derivatives
09/17/1997EP0794794A1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
09/17/1997EP0794789A1 Inhibitors of prenyl transferases
09/17/1997EP0794787A1 Compositions for the treatment of parasitic and fungal infections
09/17/1997EP0794786A1 The use of inositoltrisphosphate for the preparing of medicaments
09/17/1997EP0794784A1 Combination chemotherapy of suramin and a vinca-alkaloid or estramustine
09/17/1997EP0794774A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
09/17/1997EP0755675B1 Dermatological and/or pharmaceutical composition, process of preparation and utilization
09/17/1997EP0721328A4 Camptothecin formulations
09/17/1997EP0525123B1 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
09/17/1997CN1159830A Immunomodulators
09/17/1997CN1159828A Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
09/17/1997CN1159827A FLT-4 (fms-like tyrosine-kinase), FLT-15, variants thereof uses as growth factor inhibitors
09/17/1997CN1159811A Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
09/17/1997CN1159801A Colchicine derivatives and the therapeutical use thereof
09/17/1997CN1159444A Sulfuryl amino substituted benzoyl guanidine, preparation process and applications as medicine or diagnostic agent and the medicine containing same
09/16/1997US5668180 Alkoxyaryl compounds
09/16/1997US5668152 Protein kinase C inhibitors
09/16/1997US5667981 Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein
09/16/1997US5667786 Method for treating tumors with a toxin
09/16/1997US5667781 Enhanced inhibition of tumor cell proliferation using a combination of two monoclonal antibodies to the human transferrin receptor
09/16/1997US5667764 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
09/16/1997CA2171887A1 An anti-viral and anti-cancer agent
09/15/1997CA2200012A1 Plasmid entrapping multilamellar liposomes
09/15/1997CA2199889A1 Use of naphthalene derivatives in treating lung carcinoma
09/12/1997WO1997032994A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells
09/12/1997WO1997032991A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
09/12/1997WO1997032989A2 Recombinant aav vector-based transduction system and use of same
09/12/1997WO1997032988A1 Adeno-associated virus vector for boosting immunogenicity of cells
09/12/1997WO1997032979A1 Inhibition of proliferation of cells
09/12/1997WO1997032909A1 Betaine polymers, process for producing the same, and antiviral agents
09/12/1997WO1997032896A1 Antitumor substance extracted from hen-of-the-woods
09/12/1997WO1997032887A1 Oligonucleotide analogues
09/12/1997WO1997032882A1 PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION
09/12/1997WO1997032881A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production
09/12/1997WO1997032880A1 Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production
09/12/1997WO1997032869A1 Taxoids, preparation thereof and pharmaceutical compositions containing same
09/12/1997WO1997032856A1 4-anilinoquinazoline derivatives
09/12/1997WO1997032850A1 Mcbi analogs of cc-1065 and the duocarmycins
09/12/1997WO1997032846A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation
09/12/1997WO1997032603A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
09/12/1997WO1997032583A1 Use of csaidtm compounds as inhibitors of angiogenesis
09/12/1997WO1997032582A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
09/12/1997WO1997032578A1 Taxoid anti-tumor agents and pharmaceutical compositions thereof
09/12/1997WO1997032576A1 Use of aryl n-substituted carboxamides to kill tumors
09/12/1997WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases
09/12/1997WO1997004097A3 Human CTLA-8 and uses of CTLA-8-related proteins
09/12/1997CA2248720A1 Pyrimido[5,4-d]pyrimidines, pharmaceuticals containing these compounds, their use and processes for the preparation thereof
09/12/1997CA2248350A1 Inhibition of proliferation of cells
09/12/1997CA2248316A1 Pyrimido[5,4-d]pyrimidines, pharmaceuticals containing these compounds, their use and processes for their preparation
09/12/1997CA2248195A1 Taxoids, preparation thereof and pharmaceutical compositions containing same
09/12/1997CA2248125A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
09/12/1997CA2248109A1 Use of aryl n-substituted carboxamides to kill tumors
09/12/1997CA2247806A1 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
09/12/1997CA2247480A1 Oligonucleotide analogues
09/12/1997CA2246333A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
09/12/1997CA2244733A1 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells
09/12/1997CA2243994A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production
09/12/1997CA2199351A1 Benzothiophenes, formulations containing same, and methods
09/11/1997DE19608751A1 Adeno-assoziierter Virus-Vektor zur Steigerung der Immunogenität von Zellen Adeno-associated virus vector for enhancing the immunogenicity of cells
09/11/1997DE19608653A1 Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Pyrimido [5,4-d] pyrimidines, medicaments containing these compounds, their use and process for their preparation
09/11/1997DE19608588A1 Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Pyrimido [5,4-d] pyrimidines, medicaments containing these compounds, their use and process for their preparation
09/10/1997EP0794194A1 A process for the preparation of 2'-deoxy-2'-halocoformycins or stereoisomers thereof
09/10/1997EP0794172A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
09/10/1997EP0794171A2 Orthosubstituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic material and medicaments containing them
09/10/1997EP0793725A1 Nuclear protein serine/threonine kinases
09/10/1997EP0793721A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/10/1997EP0793719A2 Rna component of telomerase
09/10/1997EP0793669A1 L-nucleoside dimer compounds and therapeutic uses
09/10/1997EP0793667A1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them
09/10/1997EP0793649A1 18,19-dinor-vitamin d compounds
09/10/1997EP0793648A1 18-nor-vitamin d compounds
09/10/1997EP0793643A1 Matrix metalloprotease inhibitors
09/10/1997EP0793641A1 Metalloproteinase inhibitors
09/10/1997EP0793504A1 Chimeric cytokines and uses thereof
09/10/1997EP0793501A1 In vivo activation of tumor-specific cytotoxic t cells
09/10/1997EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
09/10/1997EP0793499A1 Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound
09/10/1997EP0793493A1 Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
09/10/1997EP0793492A1 Treating disorders characterised by excessive cell proliferation with sclareolide
09/10/1997EP0712403B1 Matrix metalloprotease inhibitors
09/10/1997EP0683787B1 4'-o-sulfonyl-anthracycline derivatives
09/10/1997EP0669001B1 Determination of peptide motifs on mhc molecules
09/10/1997EP0619304B1 22-oxacholecalciferol derivative and production thereof
09/10/1997EP0558635B1 Improved matrix metalloprotease inhibitors
09/10/1997CN1159192A Substituted camptothecin derivatives and process for their preparation